Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Jul-14 4:39 PM View:  | Patel Sailash Chief Financial Officer | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 26,444 | -- | -- | (100%) 26.44K to 0 | |
| 07-Jul-14 4:38 PM View: | Kaldor Stephen W Director | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 7,160 | -- | -- | (100%) 7.16K to 0 | |
| 07-Jul-14 4:39 PM View: | Almenoff June Sherie President Director | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 24,600 | -- | -- | (100%) 24.6K to 0 | |
| 07-Jul-14 4:39 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 24,318 | -- | -- | (100%) 24.32K to 0 | |
| 07-Jul-14 4:40 PM View: | Eshelman Fredric N Director 10% Owner | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 2,673,520 | -- | -- | (94%) 2.85M to 174.5K | |
| 07-Jul-14 4:39 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 8,447 | -- | -- | (100%) 8.45K to 0 | |
| 07-Jul-14 4:38 PM View: | Davis Stephen Director | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 9,308 | -- | -- | (100%) 9.31K to 0 | |
| 07-Jul-14 4:39 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 22,523 | -- | -- | (100%) 22.52K to 0 | |
| 07-Jul-14 4:40 PM View: | Eshelman Fredric N Director 10% Owner | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 174,495 | -- | -- | (100%) 174.5K to 0 | |
| 07-Jul-14 4:39 PM View: | Dixon Wendy L Director | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 7,160 | -- | -- | (100%) 7.16K to 0 | |
| 26-Jun-14 5:36 PM View: | Patel Sailash Chief Financial Officer | Furiex Pharmaceuticals, Inc. (FURX) | 24-Jun-14 | Market Option Sale | 32,928 | $104.00 | $3,424,510.00 | (55%) 59.37K to 26.44K | (< 1%) |
| 26-Jun-14 5:36 PM View: | Patel Sailash Chief Financial Officer | Furiex Pharmaceuticals, Inc. (FURX) | 24-Jun-14 | Option Exercise | 32,928 | $9.11 | $299,974.00 | 125% 26.44K to 59.37K | |
| 26-Jun-14 4:07 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 24-Jun-14 | Option Exercise | 10,368 | $17.80 | $184,550.00 | 46% 22.52K to 32.89K | |
| 26-Jun-14 4:07 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 24-Jun-14 | Market Option Sale | 10,368 | $104.12 | $1,079,520.00 | (32%) 32.89K to 22.52K | (< 1%) |
| 20-Jun-14 5:43 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 18-Jun-14 | Option Exercise | 45,691 | $9.11 | $416,245.00 | 203% 22.52K to 68.21K | |
| 20-Jun-14 5:43 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 18-Jun-14 | Market Option Sale | 45,691 | $104.11 | $4,756,890.00 | (67%) 68.21K to 22.52K | (< 1%) |
| 18-Jun-14 4:46 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 17-Jun-14 | Market Option Sale | 4,204 | $105.00 | $441,420.00 | (13%) 32.33K to 28.12K | < 1% |
| 18-Jun-14 4:46 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 17-Jun-14 | Option Exercise | 8,008 | $13.16 | $105,385.00 | 33% 24.32K to 32.33K | |
| 18-Jun-14 4:46 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 17-Jun-14 | Market Sale | 3,804 | $105.00 | $399,420.00 | (14%) 28.12K to 24.32K | < 1% |
| 18-Jun-14 4:46 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 16-Jun-14 | Market Option Sale | 66,449 | $105.01 | $6,977,590.00 | (73%) 90.77K to 24.32K | < 1% |
| 18-Jun-14 4:46 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 16-Jun-14 | Option Exercise | 62,645 | $11.79 | $738,890.00 | 223% 28.12K to 90.77K | |
| 17-Jun-14 4:46 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 13-Jun-14 | Market Sale | 3,228 | $104.25 | $336,519.00 | (13%) 25.75K to 22.52K | (< 1%) |
| 12-Jun-14 5:09 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 10-Jun-14 | Market Sale | 2,872 | $104.63 | $300,497.00 | (10%) 28.62K to 25.75K | (< 1%) |
| 12-Jun-14 5:09 PM View: | Patel Sailash Chief Financial Officer | Furiex Pharmaceuticals, Inc. (FURX) | 10-Jun-14 | Market Sale | 1,504 | $104.68 | $157,439.00 | (5%) 27.95K to 26.44K | (< 1%) |
| 12-Jun-14 5:09 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 10-Jun-14 | Market Sale | 1,746 | $104.58 | $182,597.00 | (6%) 29.87K to 28.12K | (< 1%) |
| 04-Mar-14 6:47 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 12,000 | -- | -- | 67% 17.87K to 29.87K | |
| 04-Mar-14 6:47 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 3,580 | -- | -- | 74% 4.87K to 8.45K | |
| 04-Mar-14 6:46 PM View: | Davis Stephen Director | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 3,580 | -- | -- | 62% 5.73K to 9.31K | |
| 04-Mar-14 6:47 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 13,500 | -- | -- | 89% 15.12K to 28.62K | |
| 04-Mar-14 6:47 PM View: | Dixon Wendy L Director | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 3,580 | -- | -- | 100% 3.58K to 7.16K | |
| 04-Mar-14 6:47 PM View: | Patel Sailash Chief Financial Officer | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 12,000 | -- | -- | 75% 15.95K to 27.95K | |
| 04-Mar-14 6:47 PM View: | Kaldor Stephen W Director | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 3,580 | -- | -- | 100% 3.58K to 7.16K | |
| 06-Feb-14 5:25 PM View: | Almenoff June Sherie President Director | Furiex Pharmaceuticals, Inc. (FURX) | 04-Feb-14 | Market Option Sale (Planned) | 115,113 | $115.29 | $13,271,200.00 | (82%) 139.71K to 24.6K | 9% |
| 06-Feb-14 5:25 PM View: | Almenoff June Sherie President Director | Furiex Pharmaceuticals, Inc. (FURX) | 04-Feb-14 | Option Exercise | 115,113 | $11.89 | $1,368,570.00 | 468% 24.6K to 139.71K | |
| 19-Nov-13 4:28 PM View: | Patel Sailash Chief Financial Officer | Furiex Pharmaceuticals, Inc. (FURX) | 15-Nov-13 | Grant | 1,000 | -- | -- | 7% 14.95K to 15.95K | |
| 12-Sep-13 5:43 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 10-Sep-13 | Option Exercise | 30,000 | $9.11 | $273,300.00 | 198% 15.12K to 45.12K | |
| 12-Sep-13 5:43 PM View: | Covington Paul S Senior VP-Clinical Operations | Furiex Pharmaceuticals, Inc. (FURX) | 10-Sep-13 | Market Option Sale | 30,000 | $40.89 | $1,226,700.00 | (66%) 45.12K to 15.12K | (157%) |
| 13-Aug-13 4:55 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 09-Aug-13 | Option Exercise | 7,500 | $9.11 | $68,325.00 | 209% 3.58K to 11.08K | |
| 13-Aug-13 4:55 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 09-Aug-13 | Market Option Sale | 7,500 | $39.74 | $298,050.00 | (68%) 11.08K to 3.58K | (165%) |
| 23-Jul-13 9:24 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 19-Jul-13 | Option Exercise | 20,000 | $9.11 | $182,200.00 | 112% 17.87K to 37.87K | |
| 23-Jul-13 9:24 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 19-Jul-13 | Market Option Sale (Planned) | 10,581 | $40.00 | $423,240.00 | (37%) 28.45K to 17.87K | (163%) |
| 23-Jul-13 9:24 PM View: | McIntyre Gail Frances Senior Vice President-Research | Furiex Pharmaceuticals, Inc. (FURX) | 19-Jul-13 | Payment of Exercise | 9,419 | $40.00 | $376,760.00 | (25%) 37.87K to 28.45K | (163%) |
| 02-Jul-13 5:47 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 01-Jul-13 | Gift | 15 | -- | -- | (< 1%) 3.6K to 3.58K | |
| 02-Jul-13 5:47 PM View: | Eshelman Fredric N Director 10% Owner | Furiex Pharmaceuticals, Inc. (FURX) | 30-Jun-13 | Grant | 7,161 | -- | -- | < 1% 2.84M to 2.85M | |
| 02-Jul-13 5:47 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 28-Jun-13 | Market Sale | 385 | $34.03 | $13,101.50 | (10%) 3.98K to 3.6K | (209%) |
| 02-Jul-13 5:47 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 28-Jun-13 | Gift | 2,913 | -- | -- | (42%) 6.89K to 3.98K | |
| 26-Jun-13 4:46 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 25-Jun-13 | Payment of Exercise | 400 | $33.30 | $13,319.30 | (5%) 7.29K to 6.89K | (216%) |
| 26-Jun-13 4:46 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 25-Jun-13 | Option Exercise | 1,000 | $9.11 | $9,110.00 | 16% 6.29K to 7.29K | |
| 26-Jun-13 4:46 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 24-Jun-13 | Option Exercise | 3,600 | $9.11 | $32,796.00 | 101% 3.58K to 7.18K | |
| 26-Jun-13 4:46 PM View: | Corr Peter B Director | Furiex Pharmaceuticals, Inc. (FURX) | 24-Jun-13 | Payment of Exercise | 887 | $33.12 | $29,375.10 | (12%) 7.18K to 6.29K | (218%) |
